This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor.—Stromal-derived factor (SDF-1) is the natural ligand for CXCR4, a coreceptor with CD4 for T-lymphocyte cell line–tropic human immunodeficiency virus 1 (HIV-1). Recently, a common variant, SDF1-3‘A, was identified in SDF-1, and an SDF1-3‘A/3‘A homozygous state was shown to delay the onset of acquired immunodeficiency syndrome (AIDS) in an association study involving 2857 patients.¹ The recessive protection of the SDF-1-3‘A allele was pronounced to be twice as effective as the dominant genetic restriction of AIDS conferred by CCR5 and CCR2 chemokine receptor variants.^1-3

Using a polymerase chain reaction–restriction fragment length polymorphism assay, we investigated the distribution of the SDF1-3‘A allele in 16 worldwide representative populations.¹ Our results showed that the SDF1-3‘A allele frequencies vary drastically among the populations surveyed, ranging from 2.9% to 71.4% (Table 1). African populations exhibit the lowest frequencies (2.9%-9.1%), rates that agree with the reported frequency in African Americans.¹ No SDF1-3‘A . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?